News
Sometimes called “gas station heroin,” the products are usually marketed as energy shots or cognitive supplements but ...
While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...
MONDAY, June 16, 2025 (HealthDay News) — Texas has moved to fund research into ibogaine, a psychedelic drug that may help ...
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy ...
"You’d think companies would want their products’ names to be memorable, catchy and descriptive: Windex, Duracell, KitchenAid ...
Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted ...
15hon MSN
CBD oil's popularity surges across wellness and pharmaceutical sectors, lauded for potential benefits like pain and anxiety ...
NEW YORK (AP) — All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying ...
18h
Axios on MSNDOGE cuts cause FDA to delay decision on hereditary disease drugThe Food and Drug Administration will miss a deadline this week deciding whether to approve a drug for a potentially ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
12h
GlobalData on MSNSupernus makes depression drug play with $795m Sage buyoutAfter Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results